These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10370379)

  • 41. Streptococcus sanguinis and the sera of patients with Behçet's disease stimulate membrane expression of α-enolase in human dermal microvascular endothelial cells.
    Cho S; Zheng Z; Cho SB; Choi MJ; Lee KH; Bang D
    Arch Dermatol Res; 2013 Apr; 305(3):223-32. PubMed ID: 23131860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Markers of vascular injury in Behçet's disease associated with retinal vasculitis.
    Pivetti-Pezzi P; Priori R; Catarinelli G; Meroni PL; Federici AB; Abdulaziz M; Falco M; Valesini G
    Ann Ophthalmol; 1992 Nov; 24(11):411-4. PubMed ID: 1476395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-endothelial cell antibodies in mixed connective tissue disease: frequency and association with clinical symptoms.
    Bodolay E; Csipo I; Gál I; Sipka S; Gyimesi E; Szekanecz Z; Szegedi G
    Clin Exp Rheumatol; 2004; 22(4):409-15. PubMed ID: 15301236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoantibodies against endothelial cells in patients with Behçet's disease correlation with pulmonary vasculitis.
    Hamzaoui K; Hamzaoui A; Fennira F; Mili E; Ouertani A; Ayed K; Chabbou A
    Tunis Med; 1997 Jan; 75(1):9-13. PubMed ID: 9506014
    [No Abstract]   [Full Text] [Related]  

  • 45. Serum E-selectin and beta 2-microglobulin levels in Behçet's disease.
    Karakuzu A; Aktaş A; Akçay F
    J Int Med Res; 2002; 30(1):85-8. PubMed ID: 11921504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum anti-lysozyme is associated with disease activity of Behçet's disease.
    Park JS; Kang MI; Ha YJ; Song JJ; Park YB; Lee SK; Lee SW
    Int J Rheum Dis; 2017 Feb; 20(2):261-268. PubMed ID: 26890818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
    Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antineutrophil cytoplasmic autoantibody in two patients with Behçet's disease.
    Baleva M; Kolarov Z; Nikolov K
    Nephrol Dial Transplant; 1994; 9(7):876. PubMed ID: 7818712
    [No Abstract]   [Full Text] [Related]  

  • 49. Identification of prohibitin as an antigen in Behcet's disease.
    Xun Y; Chen P; Yan H; Yang W; Shi L; Chen G; Du H
    Biochem Biophys Res Commun; 2014 Aug; 451(3):389-93. PubMed ID: 25091478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presence of circulating antibodies to a disease-specific antigen on cultured human dermal microvascular endothelial cells in patients with Behçet's disease.
    Lee KH; Bang D; Choi ES; Chun WH; Lee ES; Lee S
    Arch Dermatol Res; 1999; 291(7-8):374-81. PubMed ID: 10482005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of anti-myeloperoxidase antibodies in the serum of patients with type 1 diabetes mellitus.
    Accardo-Palumbo A; Triolo G; Giardina E; Carbone MC; Ferrante A; Triolo G
    Acta Diabetol; 1996 Jul; 33(2):103-7. PubMed ID: 8870810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha tropomyosin as a self-antigen in patients with Behçet's disease.
    Mahesh SP; Li Z; Buggage R; Mor F; Cohen IR; Chew EY; Nussenblatt RB
    Clin Exp Immunol; 2005 May; 140(2):368-75. PubMed ID: 15807864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human anti-alpha-enolase antibody in sera from patients with Behçet's disease and rheumatologic disorders.
    Lee JH; Cho SB; Bang D; Oh SH; Ahn KJ; Kim J; Park YB; Lee SK; Lee KH
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S63-6. PubMed ID: 19796536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibodies to endothelial cells in patients with Behçet's disease.
    Aydìntug AO; Tokgöz G; D'Cruz DP; Gürler A; Cervera R; Düzgün N; Atmaca LS; Khamashta MA; Hughes GR
    Clin Immunol Immunopathol; 1993 May; 67(2):157-62. PubMed ID: 8519091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating immune complexes in active Behçet's disease.
    Gupta RC; O'Duffy JD; McDuffie FC; Meurer M; Jordon RE
    Clin Exp Immunol; 1978 Nov; 34(2):213-8. PubMed ID: 737905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behçet's disease.
    Accardo-Palumbo A; Triolo G; Carbone MC; Ferrante A; Ciccia F; Giardina E; Triolo G
    Clin Exp Rheumatol; 2000; 18(4):495-8. PubMed ID: 10949726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical markers of basement membrane disturbances and occupational exposure to hydrocarbons and mixed solvents.
    Stevenson A; Yaqoob M; Mason H; Pai P; Bell GM
    QJM; 1995 Jan; 88(1):23-8. PubMed ID: 7534597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IgG anti-endothelial cell antibodies (AECA) in type I diabetes mellitus; induction of adhesion molecule expression in cultured endothelial cells.
    Triolo G; Triolo G; Accardo-Palumbo A; Carbone MC; Ferrante A; Casiglia D; Giardina E
    Clin Exp Immunol; 1998 Mar; 111(3):491-6. PubMed ID: 9528888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased titres of IgM anti-heparan sulfate antibody in Behçet's disease.
    Briani C; Doria A; Marcolongo R; Tognon S; Ruggero S; Toffanin E; Ermani M; Ghirardello A; Zampieri S; Semenzato G
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S104-7. PubMed ID: 17067438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Types of ocular attacks and lysosomal enzymes in Behçet's disease.
    Namba K; Masuda K
    Jpn J Ophthalmol; 1984; 28(1):80-8. PubMed ID: 6086997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.